Autoimmune Disease Diagnostics Market Forecast 2024-2034 | Key Players: Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, LabCorp

"The Autoimmune Disease Diagnostics Market reached US$ 4.8 billion in 2024 and is expected to reach US$ 9.9 billion by 2034, growing with a CAGR of 7.5% during the forecast period 2024-2034." As per Global Insight Services research report.

Download your exclusive sample report today: (corporate email gets priority access): https://www.globalinsightservices.com/request-sample/?id=GIS24309

United States

Recent Launches and Investments

✅ In August 2025, LabCorp launched an advanced autoimmune diagnostic panel for early-stage detection of complex autoimmune disorders. The test integrates AI-powered algorithms to enhance accuracy and reduce false positives. It targets hospitals and specialty clinics.

✅ In February 2025, Quest Diagnostics invested $20 million in R&D to expand its autoimmune disease testing portfolio. The initiative focuses on developing next-generation assays for conditions like rheumatoid arthritis and lupus, aiming to improve treatment outcomes.

Mergers and Acquisitions

✅ In September 2025, Thermo Fisher Scientific acquired a U.S.-based autoimmune diagnostics startup to enhance its immunoassay capabilities. The acquisition bolsters its position in precision healthcare solutions and accelerates global deployment.

✅ In April 2025, Bio-Rad Laboratories partnered with a diagnostic imaging firm to co-develop integrated platforms for autoimmune disease diagnostics, combining blood tests with imaging biomarkers to enhance early detection and monitoring.

Japan

Recent Launches and Investments

✅ In July 2025, Sysmex Corporation launched a next-generation autoimmune diagnostic test for early-stage inflammatory disorders. The test is designed to deliver high-sensitivity results and is optimized for hospital-based laboratories.

✅ In May 2025, Shimadzu introduced innovative immunoassay systems for autoimmune diagnostics. The system enhances throughput and supports rapid sample processing, catering to growing demand from healthcare centers.

Mergers and Acquisitions

✅ In August 2025, Hitachi partnered with a U.S. diagnostics firm to co-develop advanced autoimmune diagnostic tools. The collaboration focuses on improving test accuracy and enhancing global access to cutting-edge diagnostic technologies.

✅ In June 2025, Fujifilm Healthcare acquired a domestic autoimmune diagnostic startup, expanding its portfolio in molecular diagnostics and AI-assisted testing solutions. The acquisition strengthens its healthcare innovation pipeline.

Autoimmune Disease Diagnostics Market: Drivers

The autoimmune disease diagnostics market is experiencing robust growth due to rising prevalence of autoimmune conditions, increased awareness about early diagnosis, and advancements in biomarker research. Autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus are contributing to higher demand for precise and reliable diagnostic tools.

Technological breakthroughs in molecular diagnostics, immunoassays, and AI-based predictive algorithms are improving diagnostic accuracy and enabling personalized treatment strategies. Additionally, healthcare systems' growing focus on preventive care and long-term disease management is accelerating adoption.

Investment in R&D for novel biomarkers, wearable biosensors, and rapid point-of-care testing is further expanding the market. Public-private collaborations and cross-industry partnerships are fostering innovation, while government initiatives aimed at early detection and patient care are driving expansion. The need for cost-effective, scalable, and accurate testing solutions in both developed and emerging markets is fueling the growth trajectory of the autoimmune disease diagnostics sector.

Browse Research Report: https://www.globalinsightservices.com/reports/autoimmune-disease-diagnostics-market/

Autoimmune Disease Diagnostics Market: Major Players

Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, LabCorp, Quest Diagnostics, Sysmex Corporation, Fujifilm Healthcare.

Segment Covered in the Autoimmune Disease Diagnostics Market:

➥ By Product: Immunoassays, Molecular Diagnostics, Biosensors, Others
➥ By Application: Hospitals & Clinics, Diagnostic Centers, Home Care, Research Institutes, Others

Research Process

Both primary and secondary data sources have been used in this 60+ market research report. During the research process, a wide range of industry-impacting factors are examined, including regulatory frameworks, market dynamics, competitive landscape, historical trends, technological innovations, upcoming developments, market volatility, potential barriers, and growth opportunities.

Most Frequently Asked Questions in the Autoimmune Disease Diagnostics Market Research Industry:

➠ Who are the leading players in the Autoimmune Disease Diagnostics market and how do they compare in terms of capacity, accuracy, and profitability?
➠ What emerging trends and challenges are influencing the market?
➠ Which segments hold the largest market share and offer the highest growth potential?
➠ What are the key drivers and constraints affecting market expansion?
➠ What are the prominent strategies for sales, distribution, and commercialization in this sector?

Buy Now & Unlock 360° Market Intelligence: https://www.globalinsightservices.com/checkout/single_user/GIS24309

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Germany, France, Italy, Spain, The Netherlands, Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Colombia, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for Excel Datapack: https://www.globalinsightservices.com/checkout/excel_datapack/GIS24309

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Assessment
✅ Key Opinion Leader (KOL) Insights
✅ Consumer Behavior & Demand Trends
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Intelligence

➤ Have questions about the scope of report ? Enquiry Before Buying - https://www.globalinsightservices.com/inquiry-before-buying/GIS24309

Discover Additional Market Insights from Global Insight Services:

Asia Pacific In Vitro Diagnostics Market - https://www.globalinsightservices.com/reports/asia-pacific-in-vitro-diagnostics-market/

Central Nervous System Therapeutics Market - https://www.globalinsightservices.com/reports/central-nervous-system-therapeutics-market/

Rare Disease Clinical Trials Market - https://www.globalinsightservices.com/reports/rare-disease-clinical-trials-market/

Histology and Cytology Consumables Market - https://www.globalinsightservices.com/reports/histology-and-cytology-consumables-market/

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes, DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Us:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.